211 related articles for article (PubMed ID: 24804859)
1. HIV sexual transmission risk among serodiscordant couples: assessing the effects of combining prevention strategies.
Lasry A; Sansom SL; Wolitski RJ; Green TA; Borkowf CB; Patel P; Mermin J
AIDS; 2014 Jun; 28(10):1521-9. PubMed ID: 24804859
[TBL] [Abstract][Full Text] [Related]
2. Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness.
Heffron R; Ngure K; Velloza J; Kiptinness C; Quame-Amalgo J; Oluch L; Thuo N; Njoroge J; Momanyi R; Gakuo S; Mbugua S; Morrison S; Haugen H; Chohan B; Celum C; Baeten JM; Mugo N
J Int AIDS Soc; 2019 Apr; 22(4):e25261. PubMed ID: 30957420
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.
Ying R; Sharma M; Heffron R; Celum CL; Baeten JM; Katabira E; Bulya N; Barnabas RV
J Int AIDS Soc; 2015; 18(4 Suppl 3):20013. PubMed ID: 26198348
[TBL] [Abstract][Full Text] [Related]
4. Strategies used by gay male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries.
Bavinton BR; Prestage GP; Jin F; Phanuphak N; Grinsztejn B; Fairley CK; Baker D; Hoy J; Templeton DJ; Tee BK; Kelleher A; Grulich AE;
J Int AIDS Soc; 2019 Apr; 22(4):e25277. PubMed ID: 30983155
[TBL] [Abstract][Full Text] [Related]
5. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
Rodger AJ; Cambiano V; Bruun T; Vernazza P; Collins S; van Lunzen J; Corbelli GM; Estrada V; Geretti AM; Beloukas A; Asboe D; Viciana P; Gutiérrez F; Clotet B; Pradier C; Gerstoft J; Weber R; Westling K; Wandeler G; Prins JM; Rieger A; Stoeckle M; Kümmerle T; Bini T; Ammassari A; Gilson R; Krznaric I; Ristola M; Zangerle R; Handberg P; Antela A; Allan S; Phillips AN; Lundgren J;
JAMA; 2016 Jul; 316(2):171-81. PubMed ID: 27404185
[TBL] [Abstract][Full Text] [Related]
6. Is PrEP necessary during natural conception in HIV-1-serodiscordant couples on ART with suppressed viral load? A retrospective cohort analysis.
Sun L; Liu A; Li J; Shao Y; Li Q; Ye J; Zhang H; Li Z; Wang H
BMC Infect Dis; 2020 Mar; 20(1):195. PubMed ID: 32138673
[TBL] [Abstract][Full Text] [Related]
7. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
[TBL] [Abstract][Full Text] [Related]
8. Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention.
Irungu EM; Heffron R; Mugo N; Ngure K; Katabira E; Bulya N; Bukusi E; Odoyo J; Asiimwe S; Tindimwebwa E; Celum C; Baeten JM;
BMC Infect Dis; 2016 Oct; 16(1):571. PubMed ID: 27751179
[TBL] [Abstract][Full Text] [Related]
9. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.
Hallett TB; Baeten JM; Heffron R; Barnabas R; de Bruyn G; Cremin Í; Delany S; Garnett GP; Gray G; Johnson L; McIntyre J; Rees H; Celum C
PLoS Med; 2011 Nov; 8(11):e1001123. PubMed ID: 22110407
[TBL] [Abstract][Full Text] [Related]
10. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
[TBL] [Abstract][Full Text] [Related]
11. Differences in awareness of and willingness to use pre-exposure prophylaxis and anticipated condom use among serodiscordant couples in Taiwan.
Ko NY; Wu HJ; Strong C; Li CW; Ku WW; Hsu ST
AIDS Care; 2018 Oct; 30(10):1306-1310. PubMed ID: 29845871
[TBL] [Abstract][Full Text] [Related]
12. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
[TBL] [Abstract][Full Text] [Related]
13. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
Gilbert HN; Wyatt MA; Pisarski EE; Muwonge TR; Heffron R; Katabira ET; Celum CL; Baeten JM; Haberer JE; Ware NC
J Acquir Immune Defic Syndr; 2019 Nov; 82(3):265-274. PubMed ID: 31609925
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 prevention for HIV-1 serodiscordant couples.
Curran K; Baeten JM; Coates TJ; Kurth A; Mugo NR; Celum C
Curr HIV/AIDS Rep; 2012 Jun; 9(2):160-70. PubMed ID: 22415473
[TBL] [Abstract][Full Text] [Related]
15. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of ART and condom use for prevention of sexual HIV transmission in serodiscordant couples: a systematic review and meta-analysis.
Liu H; Su Y; Zhu L; Xing J; Wu J; Wang N
PLoS One; 2014; 9(11):e111175. PubMed ID: 25369471
[TBL] [Abstract][Full Text] [Related]
17. Strategies to prevent HIV transmission to serodiscordant couples.
Hallal RC; Raxach JC; Barcellos NT; Maksud I
Rev Bras Epidemiol; 2015 Sep; 18 Suppl 1():169-82. PubMed ID: 26630306
[TBL] [Abstract][Full Text] [Related]
18. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.
Bavinton BR; Pinto AN; Phanuphak N; Grinsztejn B; Prestage GP; Zablotska-Manos IB; Jin F; Fairley CK; Moore R; Roth N; Bloch M; Pell C; McNulty AM; Baker D; Hoy J; Tee BK; Templeton DJ; Cooper DA; Emery S; Kelleher A; Grulich AE;
Lancet HIV; 2018 Aug; 5(8):e438-e447. PubMed ID: 30025681
[TBL] [Abstract][Full Text] [Related]
19. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
[TBL] [Abstract][Full Text] [Related]
20. "I just believe there is a risk" understanding of undetectable equals untransmissible (U = U) among health providers and HIV-negative partners in serodiscordant relationships in Kenya.
Ngure K; Ongolly F; Dolla A; Awour M; Mugwanya KK; Irungu E; Mugo N; Bukusi EA; Morton J; Odoyo J; Wamoni E; Barnabee G; Peebles K; O'Malley G; Baeten JM;
J Int AIDS Soc; 2020 Mar; 23(3):e25466. PubMed ID: 32144888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
